LGVN Longeveron Inc: Total Debt to Equity Ratio

Longeveron Inc. - graphic logo of issuer LGVN

Longeveron Inc. (LGVN) focuses its biotech business on developing stem cell-based treatments for age-related diseases, ensuring long-term demand for its innovations. This chart of GURU.Markets quotes reflects a debt-to-equity ratio of 0.06. High scientific and technical potential in Alzheimer's therapy is coupled with a lack of profitability, meaning financing relies exclusively on investment inflows.

LGVN: Longeveron Debt to Capital 07/04/2022 - 10/31/2026

Analytical breakdowns for Longeveron Inc.

- price and consensus price forecast:
Price Chart Longeveron|LGVN - Analyst Median Target
- company stock capitalization data:
Market Valuation Longeveron|LGVN - Aggregate Business Value
- book capitalization information:
Book Value per Share Longeveron|LGVN - Total Stockholders' Equity|Market Value to Book Value Ratio longeveron.com|LGVN - Cumulative Company Assets
- debt burden and liquidity indicators:
Total Debt to Capital Longeveron Inc.|LGVN - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Longeveron Inc.|LGVN - Company Cumulative Debt|Debt to Book Capitalization Ratio Longeveron|LGVN - Company Long-Term Debt|Company Short-Term Debt Longeveron|Quick Liquidity longeveron.com
- earnings and valuation multiples information:
LGVN - Net Financial Result
Fundamental company analysis:LGVN, Longeveron
Finished products of Longeveron Corporation

This ratio measures the proportion of debt obligations relative to equity, determining the degree of financial autonomy and the risks associated with the business's debt load. By analyzing the capital structure metric (total debt to equity), investors assess the stability of Longeveron Inc. (LGVN), where low leverage is critical to supporting a diversified stem cell research portfolio in the event of potential failures in individual clinical trials.

Key competitors

Debt to Equity Mesoblast|Lineage Cell Therapeutics Inc (LCTX) - Total Debt to Capital Coefficient|Total Debt to Equity Ratio SRZN (Surrozen Corp)|Aggregate Debt to Capital CCEL|Total Debt to Capital FBLG (FibroBiologics)|BioRestorative Therapies Inc (BRTX) - Debt to Capital|CELZ - Debt to Equity